Mesirow Institutional Investment Management Inc. decreased its stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 4.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 116,771 shares of the medical instruments supplier's stock after selling 5,306 shares during the quarter. ICU Medical makes up 1.4% of Mesirow Institutional Investment Management Inc.'s holdings, making the stock its 13th biggest position. Mesirow Institutional Investment Management Inc. owned about 0.48% of ICU Medical worth $18,119,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. Arizona State Retirement System raised its position in shares of ICU Medical by 1.0% in the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock valued at $1,044,000 after buying an additional 65 shares during the last quarter. Huntington National Bank raised its holdings in ICU Medical by 6.2% in the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock valued at $218,000 after acquiring an additional 82 shares during the last quarter. Equitable Trust Co. lifted its stake in ICU Medical by 1.6% in the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after purchasing an additional 84 shares in the last quarter. LPL Financial LLC boosted its holdings in shares of ICU Medical by 2.0% during the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock worth $747,000 after purchasing an additional 93 shares during the last quarter. Finally, Alliancebernstein L.P. grew its position in shares of ICU Medical by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock valued at $4,051,000 after purchasing an additional 136 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.
ICU Medical Trading Up 1.2 %
Shares of NASDAQ:ICUI traded up $1.60 during mid-day trading on Wednesday, reaching $132.28. 305,914 shares of the company were exchanged, compared to its average volume of 272,497. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The firm's 50-day simple moving average is $144.83 and its 200 day simple moving average is $158.80. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26. The firm has a market cap of $3.24 billion, a price-to-earnings ratio of -28.95 and a beta of 0.86.
Analyst Upgrades and Downgrades
Several analysts have issued reports on ICUI shares. Raymond James set a $97.00 target price on ICU Medical in a report on Wednesday, March 12th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday, April 16th. Finally, KeyCorp decreased their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a report on Monday. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $162.67.
Check Out Our Latest Stock Analysis on ICUI
About ICU Medical
(
Free Report)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
Recommended Stories
Before you consider ICU Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.
While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
